Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS Patients
Open Access
- 1 December 2005
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (12) , 1455-1457
- https://doi.org/10.1128/cdli.12.12.1455-1457.2005
Abstract
The serum antibodies to severe acute respiratory syndrome (SARS) coronavirus of 18 SARS patients were checked at 1 month and every 3 months after disease onset. All of them except one, who missed blood sampling at 1 month, tested positive for the immunoglobulin G (IgG) antibody at 1 month. Fifteen out of 17 tested positive for the IgM antibody at 1 month. The serum IgM antibody of most patients became undetectable within 6 months after the onset of SARS. The IgG antibody of all 17 patients, whose serum was checked 1 year after disease onset, remained positive.Keywords
This publication has 14 references indexed in Scilit:
- Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with PseudotypesEmerging Infectious Diseases, 2005
- Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2004
- Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS PatientsEmerging Infectious Diseases, 2004
- SARS in Hospital Emergency RoomEmerging Infectious Diseases, 2004
- Severe acute respiratory syndromeCurrent Opinion in Infectious Diseases, 2004
- The Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Treatment of severe acute respiratory syndrome in health-care workersThe Lancet, 2003
- Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1Emerging Infectious Diseases, 2003
- Profile of Specific Antibodies to the SARS-Associated CoronavirusNew England Journal of Medicine, 2003
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003